On Friday, Cognition Therapeutics Inc (CGTX) stock saw a modest uptick, ending the day at $0.63 which represents no change from the prior close of of $0.63. The stock opened at $0.64 and touched a low ...

Researchers at the California Institute of Technology have unveiled a startling revelation about the human mind: our thoughts ...

Language and social cognition are fundamental to human communication. But how do these capacities interact? In a review paper ...

This second route to joy is demonstrated in the prayer of another Old Testament prophet, Habakkuk. In response to his ...

AI isn't just changing how we think—it's dissolving the boundaries between human and machine cognition in unexpected ways.

Cognition Therapeutics' CT1812 improves dementia with Lewy bodies outcomes, reducing anxiety, hallucinations, and functional ...

Cognition Therapeutics (CGTX) announced topline results from the exploratory Phase 2 ‘SHIMMER’ study demonstrating CT1812 ...

Christmas edition of BMJ (British Medical Journal) was just published. It brings with it the same characteristic light-hearted, joyful, yet still scientific, spirit of the holidays. There were several ...

By Vijay Kumar Malesu A recent study explores the relationship between brain connectivity and intelligence, highlighting the ...

Higher frequency of antibiotic use was not associated with dementia or cognitive impairment; neither was long-term use. No ...